Clinical Trials Logo

Clinical Trial Summary

Incontinence-associated dermatitis (IAD) is an inflammation of the skin that occurs as a result of urine or feces contact on the perineal or perigenital region in adults. Lesions are typically located in the convex regions covered by diapers. The perineal region is the most affected, bringing pain and discomfort to the participant. The prevention and treatment of IAD must essentially follow two interventions: the control of incontinence/dampness and the implementation of a structured regimen of perineal care, seeking results for the restoration of skin integrity. Therefore, the gold standard for the treatment of IAD is skin hygiene, moisture control, and the use of a skin protector to restore skin integrity. Photobiomodulation has been used with excellent results in restoring skin integrity in acute and chronic wounds, but so far it has not been tested for IAD. To evaluate the effect of photobiomodulation in the treatment of incontinence-associated dermatitis in adults. A total of 78 with participant who developed lesions that present erythema with intact skin and erythema with loss of continuity, resulting from IAD, will be included in the study. Participants will be randomly divided into 2 groups: Control group use of liquid protective film in spray + FBM simulation (placebo), Experimental group (n=39) - use of liquid protective film in spray + FBM. FBM will be performed with a 660 nm 100mW diode laser, 2 J per point, in 8 points and radiant exposure of 707 J/cm2. FBM will be applied once a day every 24 hours for 3 days in a row. Both groups will continue with standard daily skin care and diaper changes every 3 hours. The primary endpoint was chosen for the 7-day IAD lesion cure rate study. A photographic record of the lesion area and measurements will be performed using a disposable ruler with the participant in a lithotomous position on the days of the evaluations. For the classification and characterization of the severity of IAD, the Ghent Global IAD Categorization tool will be applied. In addition, the size of the area will be analyzed using ImageJ software program. For pain assessment, the visual analog scale will be used in conscious participants and the BPS scale in participants with cognitive impairment and who are intubated. All outcomes will be evaluated at baseline, at 24 hours, 3 days, and 7 days.


Clinical Trial Description

Incontinence-associated dermatitis (IAD) is an inflammation of the skin that occurs as a result of urine or feces contact on the perineal or perigenital region in adults. Lesions are typically located in the convex regions covered by diapers. The perineal region is the most affected, bringing pain and discomfort to the participant. The prevention and treatment of IAD must essentially follow two interventions: the control of incontinence/dampness and the implementation of a structured regimen of perineal care, seeking results for the restoration of skin integrity. Therefore, the gold standard for the treatment of IAD is skin hygiene, moisture control, and the use of a skin protector to restore skin integrity. Photobiomodulation has been used with excellent results in restoring skin integrity in acute and chronic wounds, but so far it has not been tested for IAD. Materials and methods: A controlled, randomized, and blinded clinical study will be carried out on participants hospitalized in the Intensive Care sector, oncology, and coronary care unit of Hcor Associação Beneficente Síria. A total of 78 participants who developed lesions that present erythema with intact skin and erythema with loss of continuity, resulting from IAD, will be included in the study. Participants will be randomly divided into 2 groups: Control group (n=39) - use of liquid protective film in spray + FBM simulation (placebo), Experimental group (n=39) - use of liquid protective film in spray + FBM. FBM will be performed with a 660 nm 100mW diode laser, 2 J per point, in 8 points and radiant exposure of 707 J/cm2. FBM will be applied once a day every 24 hours for 3 days in a row. Both groups will continue with standard daily skin care and diaper changes every 3 hours. The primary endpoint was chosen for the 7-day IAD lesion cure rate study. A photographic record of the lesion area and measurements will be performed using a disposable ruler with the participant in a lithotomous position on the days of the evaluations. For the classification and characterization of the severity of IAD, the Ghent Global IAD Categorization tool will be applied. In addition, the size of the area will be analyzed using ImageJ software program. Pain will be assessed using a pain scale and a satisfaction questionnaire. All outcomes will be evaluated at baseline, at 24 hours, 3 days, and 7 days. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05471180
Study type Interventional
Source University of Nove de Julho
Contact
Status Withdrawn
Phase N/A
Start date August 20, 2022
Completion date January 20, 2023

See also
  Status Clinical Trial Phase
Completed NCT02893501 - Infant Microbiome in Diaper Rash N/A
Completed NCT05328232 - The Effect Of Olive Oil on Diaper Rash N/A
Completed NCT02996357 - Risk Factors for Incontinence-Associated Dermatitis (IAD) in ICU Patients Suffering From Fecal Incontinence N/A
Completed NCT05427760 - Effect Of Using Oxygen On The Diaper Dermatitis In Infants N/A
Completed NCT03685929 - Histopathological Comparison Between Superficial Pressure Ulcers and Incontinence-associated Dermatitis
Completed NCT05599763 - Multicenter, National, Observational, Prospective, Real-life Study Evaluating the Performance of 2% Aqueous Eosin in Children With Diaper Rash
Completed NCT03309059 - Comparison of Barrier Products in the Prevention of Incontinence-associated Dermatitis in Hospitalized Elderly N/A
Terminated NCT02475512 - Comparison of Wash Wipes and Standard Care in the Prevention of Incontinence-associated Dermatitis in Elderly N/A
Completed NCT00702507 - Prospective Two-Year Study to Assess Miconazole Nitrate Resistance in Neonates and Infants Phase 4
Completed NCT03138057 - BM Characterization Pilot N/A
Withdrawn NCT03425851 - Diaper Distribution in Low-Income Infants N/A
Completed NCT00219466 - Clinical Study to Evaluate the Efficacy and Safety of Two Marketed Investigational Products in Children With Diaper Rash Phase 4
Withdrawn NCT01167465 - Determination of Safety and Consumers' Satisfaction of Moussik Versus Desitin Creamy Ointment in Diaper Rash Prophylaxis Phase 4
Completed NCT04210674 - Effects of Argan Spinosa Oil in the Treatment of Diaper Dermatitis in Infants and Toddlers N/A
Terminated NCT02299206 - CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants N/A
Completed NCT06015217 - A Clinical Study to Assess the Efficacy and Safety of a Healing Ointment on Diaper Rash Phase 4
Completed NCT05892081 - Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit Phase 4
Completed NCT03640897 - Evaluation of the Safety and Performance of LiNiDERM® in the Prevention of Infant Diaper Rash N/A